BACKGROUND AND OBJECTIVES: The purpose of our study is to evaluate the incidence of cervical recurrence after laparoscopic supracervical hysterectomy for @entity43 debulking or staging. METHODS: From a prospective surgical database, we identified 51 cases of laparoscopic supracervical hysterectomy for @entity43 debulking or staging. No cases were excluded. RESULTS: From 2009 to 2012, 51 @entity1 were identified. The median age was 62 years (range, 32-83 years), and the median body mass index was 29 kg/m(2) (range, 16-41 kg/m(2)). Medical comorbidities were present in 40 @entity1 (78%), and 53% had prior abdominal surgery. The median operative time was 2 hours (range, 1-3.5 hours), and the median @entity190 was 200 mL (range, 50-900 mL). The median length of stay was 1 day (range, 0-12 days). The stage was I in 12 @entity1 , II in 6, and III/IV in 33. At a median follow-up time of 1.7 years (range, 0.3-2.6 years), 20 @entity1 (39%) had recurrence of @entity5 , with a median time of recurrence of 1.1 years (range, 0.3-2.3 years). All recurrences were in the abdomen or pelvis except for 1 axillary node recurrence and 1 recurrence in the distal vagina. There were no recurrences in the remaining cervical stump. No @entity1 had a postoperative vaginal cuff infection. Among the 104 cycles of intraperitoneal chemotherapy, there was no vaginal leakage of intraperitoneal chemotherapy. CONCLUSION: Laparoscopic supracervical hysterectomy for @entity43 debulking or staging does not result in cervical recurrence.

Laparoscopy-assisted supracervical hysterectomy for XXXX : cervical recurrence.

@entity43 :: ('MESH:D010051', 'Disease') :: ['ovarian cancer'] @entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity190 :: ('MESH:D006473', 'Disease') :: ['blood loss'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cancer']
@entity43 :: (MESH:D010051,Disease) :: ['ovarian cancer']
